Search

everythinglearnresearchcommunity

for

Search:↓

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

New method makes important drug ingredients more easily without needing extra purification steps.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Potassium iodide prevents hair loss and reduces toxicity from thallium acetate.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.

Targeting ornithine decarboxylase can help prevent skin cancer.

CTP-543 is generally safe for treating alopecia areata.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Thallium poisoning from contaminated cake caused severe health issues in Baghdad, highlighting the need to ban thallium as a rodenticide.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

A hair-growth formula with cystine and thiamin helps protect skin cells against UV damage and improves their growth.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Compound 15a was effective in inhibiting 5α-reductase.